Annual Report

Overview

The report presents the Taisho Pharmaceutical Group's mission, operating structure and fiscal 2018 performance. Consolidated net sales were ¥280,092 million for the year ended March 31, 2018. The company highlights gender-related workforce initiatives, including a 13.2% female-manager ratio in April 2018. Its environmental activity report records 42,691 tons of CO2 emissions from specified Saitama offices, down 11.6% against the baseline, alongside waste and energy-management initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2017-2018
Period: 1 April 2017 – 31 March 2018
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services